In developed nations, prostate cancer is the most commonly diagnosed non-cutaneous malignancy among males. Standard forms of treatment for prostate cancer detected at a localized stage include radical ...

The proapoptotic protein, prostate apoptosis response-4 (Par-4), acts as a tumor suppressor in prostate cancer cells. The serine/threonine kinase casein kinase 2 (CK2) has a well-reported role in ...

Many men who have aggressive but localized prostate cancer have to have a radical prostatectomy (RP), where the whole of the prostate gland is removed with the surrounding structures. The treatment ...

Among patients with prostate cancer who received MRI-guided stereotactic body radiation therapy (SABR), more than 80% demonstrated “classic” neurovascular bundle patterns and over 96% showed more than ...

Recent advances in the delivery of radiation therapy for prostate cancer are fueling a new trend of providing higher radiation doses over shorter periods of time. But does the daily increase in ...

Please provide your email address to receive an email when new articles are posted on . Exercise 3 days a week conferred more benefit than usual care for men with prostate cancer and erectile ...

Please provide your email address to receive an email when new articles are posted on . Exercise 3 days per week improved sexual function for men with prostate cancer vs. usual care. Exercise also ...

Androgen receptor (AR) functions as a ligand-dependent transcription factor to regulate its downstream signaling for prostate cancer progression. AR complex formation by multiple transcription factors ...

Efficacy of Prophylactic Low–Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial Patients with prostate cancer were assessed before or ...

John P. Mulhall, MD John P. Mulhall, MD, director of the Male Sexual and Reproductive Medicine Program at Memorial Sloan-Kettering Cancer Center in New York City, has written a new book titled Saving ...